Myovant Sciences Ltd. Common Shares (MYOV) Social Stream
MYOVANT SCIENCES LTD (MYOV) Price Targets From Analysts
Use the tables below to see what analysts covering MYOVANT SCIENCES LTD think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-14 | 4 | $45 | $23 | $30.75 | $26.98 | 13.97% |
| 2022-01-19 | 4 | $45 | $21 | $30.25 | $26.98 | 12.12% |
| 2022-01-27 | 4 | $45 | $21 | $29.75 | $26.98 | 10.27% |
| 2022-02-15 | 3 | $40 | $19 | $27.333 | $26.98 | 1.31% |
| 2022-07-21 | 3 | $40 | $12 | $23.75 | $26.98 | -11.97% |
| 2022-07-28 | 4 | $40 | $12 | $23.25 | $26.98 | -13.83% |
| 2022-08-02 | 4 | $40 | $10 | $20.6 | $26.98 | -23.65% |
| 2022-08-09 | 4 | $40 | $10 | $22.8 | $26.98 | -15.49% |
| 2022-10-19 | 3 | $40 | $10 | $23.25 | $26.98 | -13.83% |
| 2022-10-25 | 5 | $40 | $10 | $26 | $26.98 | -3.63% |
| 2022-10-26 | 5 | $27 | $10 | $22.75 | $26.98 | -15.68% |
The Trend in the Analyst Price Target
MYOV's average price target has moved down $3.96 over the prior 29 months.
Over the past 28 weeks, MYOV's average upside potential has been 60.9%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-07-28 | 4 | 40 | 12 | 23.25 | 13.21 | 76% |
| 2022-08-09 | 4 | 40 | 10 | 23.25 | 16.68 | 39.39% |
| 2022-08-09 | 4 | 40 | 10 | 22.80 | 16.68 | 36.69% |
| 2022-10-19 | 3 | 40 | 10 | 23.25 | 24.11 | -3.57% |
| 2022-10-25 | 5 | 40 | 10 | 26.00 | 26.72 | -2.69% |
MYOV Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.6 | 1 | 0 | 4 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
MYOV's average broker recommendation rating worsened by 0.83 over the prior 35 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MYOV as an investment opportunity.
- MYOV has a greater upside potential (average analyst target price relative to current price) than 151.4% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, MYOVANT SCIENCES LTD's number of analysts covering the stock is greater than 209.77% of them.
- In terms of how MYOVANT SCIENCES LTD fares relative to stocks in the mid market cap category, note that its variance in analysts' estimates is lower than -1171.73% of that group.
- MYOVANT SCIENCES LTD's average analyst price target is higher than 525.11% of stocks in the mid market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to MYOVANT SCIENCES LTD are ORGO, NBRV, and ANAB.
View All Top Stocks by Price Target
Make investment decisions regarding MYOV using the data that counts. Try POWR Ratings for free.